NSE - SMEListed
Q-Line Biotech Limited
Company websiteQ-Line Biotech Limited targets ₹62,53,200 crore, split as fresh issue ₹62,53,200 crore and OFS ₹0 crore.
The offer represents 400 shares. Apply from 21-05-2026 to 25-05-2026. Allotment on 26-05-2026, listing expected on 29-05-2026. Remember: subscription demand will influence listing-day price movements.
Start Date21-05-2026
End Date25-05-2026
Listing Date29-05-2026
Allotment Date26-05-2026
Current Price₹452
GMP₹95 (27.70%)
Lot Size400 Shares
Subscription102.49 Times
Face Value₹10 per share
Listing atNSE
Issue Price₹326 - ₹343
Pre Issue₹1,70,74,999
Post Issue₹2,33,28,199
Issue Size₹62,53,200
(aggregating up to 214.48 Cr)
(aggregating up to 214.48 Cr)
Fresh Issue₹62,53,200
(aggregating up to 214.48 Cr)
(aggregating up to 214.48 Cr)
Offer For Sale-
Advertisement
The Grey Market Premium (GMP) for Q-Line Biotech Limited is currently around ₹95 (27.70%). This indicates an estimated listing price of approximately ₹421 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
28 May 2026, 08:51 | ₹343 | ₹95 | ₹438 (27.70%) |
27 May 2026, 10:20 | ₹343 | ₹105 | ₹448 (30.61%) |
28 May 2026, 07:52 | ₹343 | ₹98 | ₹441 (28.57%) |
28 May 2026, 05:31 | ₹343 | ₹102 | ₹445 (29.74%) |
28 May 2026, 05:18 | ₹343 | ₹93 | ₹436 (27.11%) |
27 May 2026, 04:35 | ₹343 | ₹97 | ₹440 (28.28%) |
27 May 2026, 07:22 | ₹343 | ₹93 | ₹436 (27.11%) |
27 May 2026, 05:29 | ₹343 | ₹88 | ₹431 (25.66%) |
27 May 2026, 04:19 | ₹343 | ₹93 | ₹436 (27.11%) |
26 May 2026, 12:14 | ₹343 | ₹88 | ₹431 (25.66%) |
25 May 2026, 10:21 | ₹343 | ₹85 | ₹428 (24.78%) |
26 May 2026, 06:30 | ₹343 | ₹97 | ₹440 (28.28%) |
25 May 2026, 09:24 | ₹343 | ₹83 | ₹426 (24.20%) |
25 May 2026, 09:15 | ₹343 | ₹70 | ₹413 (20.41%) |
22 May 2026, 16:37 | ₹343 | ₹106 | ₹449 (30.90%) |
25 May 2026, 07:42 | ₹343 | ₹102 | ₹445 (29.74%) |
25 May 2026, 09:42 | ₹343 | ₹92 | ₹435 (26.82%) |
25 May 2026, 09:10 | ₹343 | ₹97 | ₹440 (28.28%) |
22 May 2026, 05:37 | ₹343 | ₹102 | ₹445 (29.74%) |
21 May 2026, 09:50 | ₹343 | ₹99 | ₹442 (28.86%) |
21 May 2026, 07:06 | ₹343 | ₹106 | ₹449 (30.90%) |
21 May 2026, 04:08 | ₹343 | ₹114 | ₹457 (33.24%) |
20 May 2026, 13:23 | ₹343 | ₹91 | ₹434 (26.53%) |
20 May 2026, 15:00 | ₹343 | ₹113 | ₹456 (32.94%) |
20 May 2026, 12:43 | ₹343 | ₹85 | ₹428 (24.78%) |
19 May 2026, 11:41 | ₹343 | ₹79 | ₹422 (23.03%) |
20 May 2026, 12:16 | ₹343 | ₹80 | ₹423 (23.32%) |
19 May 2026, 08:07 | ₹343 | ₹79 | ₹422 (23.03%) |
19 May 2026, 06:35 | ₹343 | ₹68 | ₹411 (19.83%) |
18 May 2026, 11:58 | ₹343 | ₹57 | ₹400 (16.62%) |
19 May 2026, 09:22 | ₹343 | ₹88 | ₹431 (25.66%) |
18 May 2026, 07:27 | ₹343 | ₹40 | ₹383 (11.66%) |
17 May 2026, 14:28 | ₹343 | ₹0 | ₹343 (0.00%) |
18 May 2026, 07:14 | ₹343 | ₹22 | ₹365 (6.41%) |
Financials overview In Crores
Here is a quick look at the recent financial performance of Q-Line Biotech Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Dec-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
EPS | 23.57 | 28.63 | 21.87 | 20.38 |
ROE | 16.88 | 23.74 | 21.29 | 25.20 |
ROCE | 13.32 | 17.66 | 19.25 | 22.14 |
RONW | 0 | 0 | 0 | 0 |
PRE IPO(PE) | 0 | 0 | 0 | 0 |
POST IPO(PE) | 0 | 0 | 0 | 0 |
Subscription Details (No. of Shares)
The below shows how many shares were subscribed by each investor category in the Q-Line Biotech Limited IPO. These numbers help you understand where the demand is coming from – whether it’s retail investors, QIBs, or NIBs. Higher subscription usually indicates strong interest and confidence from the market.
Subscription Demand (in ₹ Crore)
| Category | Offered | Demand | Times |
|---|---|---|---|
QIBs | ₹40.75 | 5050.24 | 123.93 |
FIIs | ₹0 | 711.11 | 0.00 |
FIs | ₹0 | 1107.77 | 0.00 |
Mutual Funds | ₹0 | 94 | 0.00 |
Others | ₹0 | 3137.37 | 0.00 |
RETAIL | ₹71.32 | 5094.98 | 71.44 |
HNIs 2+ | ₹10.19 | 829.29 | 81.38 |
HNIs 10+ | ₹20.39 | 3645.72 | 178.80 |
Total | ₹142.65 | 14620.23 | 102.49 |
Application Wise Breakup (Approx. no of Apps)
| Category | Reserved | Applied | Times |
|---|---|---|---|
QIB | 0 | 197 | 0.00 |
NIB | 0 | 49,781 | 0.00 |
RETAIL | 2,599 | 1,85,677 | 71.44 |
HNIs(10L +) | 495 | 31,162 | 62.95 |
HNIs (2-10L) | 248 | 18,619 | 75.08 |
Total | 3,342 | 2,35,458 | 70.45 |
The IPO reservation for Q-Line Biotech Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
Anchor | 28.48% | 17,81,200 |
QIB | 19.00% | 11,88,000 |
HNI | 14.26% | 8,91,600 |
RETAIL | 33.25% | 20,79,200 |
Market Maker | 5.01% | 3,13,200 |
TOTAL | 100.00% | 62,53,200 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 2 | 800 | ₹2,74,400 | |
sHNI | 3 | 1,200 | ₹4,11,600 | |
bHNI | 8 | 3,200 | ₹10,97,600 |
Below you can find the official contact details of Q-Line Biotech Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: support@purvashare.com
Phone: +91 5222435570
Website: https://qlinebiotech.com/
Address: 298-281, Transport Nagar, Kanpur Road Adjacent Transport Nagar Metro Station Lucknow, Uttar Pradesh, 226012
IPO Registrar
Advertisement